A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has found that women with early-stage cervical cancer who received radiation plus chemotherapy reported a greater short-term decline ...
Oct 22, 2025
0
0
Has a camouflaged athlete running on a dirt road ever shouted health advice through your phone? Sometimes these videos are motivational and get you off the couch to start exercising; sometimes they're educational. But can ...
Oct 22, 2025
0
2
The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers containing acetaminophen, calling the request "unsupported by the scientific evidence and legally and ...
Oct 22, 2025
0
1
Zocilurtatug pelitecan (zoci), also known as ZL-1310, an investigational antibody-drug conjugate (ADC) that targets the protein DLL3, demonstrated both safety and capacity to induce anticancer responses in patients with extensive-stage ...
Oct 22, 2025
0
0
For patients with inflammatory bowel disease (IBD), alterations in gut microbiota are associated with health-related quality of life (HRQoL) outcomes, according to a study published online Sept. 29 in The American Journal ...
Oct 22, 2025
0
0
An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing toward more serious conditions, such as cirrhosis or liver ...
Oct 22, 2025
0
1
A new peer-reviewed study in the journal Marketing Science finds that direct-to-consumer (DTC) advertising for prescription smoking-cessation drugs meaningfully reduces cigarette use. At the same time, the research found ...
Oct 22, 2025
0
0
The price tag of health insurance from employers keeps getting bigger across the U.S., and the increases this year are fueling concerns over medical spending across all health insurance markets.
Oct 22, 2025
1
0
Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...
Oct 22, 2025
0
0
Elironrasib led to meaningful and durable responses in patients with metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC), including after prior treatment with KRAS G12C inhibitors and in the presence of features ...
Oct 22, 2025
0
0
